Clinical Trial Update: Efficacy and Safety of Rotigotine in the Treatment of Patients With Early Stage of Primary Parkinson's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating the efficacy and safety of rotigotine in early-stage Parkinson's disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Rotigotine (rotigotine)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED